Texas Health Presbyterian Hospital Allen | |
1105 Central Expressway North, Allen, Texas 75013 | |
(972) 747-6197 | |
Name | Texas Health Presbyterian Hospital Allen |
---|---|
Type | Acute Care Hospital |
Location | 1105 Central Expressway North, Allen, Texas |
Ownership | Government - Federal |
Emergency Services | Yes |
Medicare ID (CCN) | 450840 |
NPI Number | 1548291883 |
Organization Name | TEXAS HEALTH PRESBYTERIAN HOSPITAL ALLEN |
Address | 1105 Central Expresseway N., Allen, TX 75013 |
Hospital Type | General Acute Care Hospital |
Phone Number | 972-747-6197 |
News Archive
The National Academy of Sciences and the National Academy of Medicine are launching a major initiative to guide decision making about controversial new research involving human gene editing. Human gene-editing technologies, such as CRISPR-Cas9, may lead to promising new treatments for disease.
Impax Laboratories, Inc. today announced that it has entered into a product development and supply agreement with IGI Laboratories, Inc., a formulation and manufacturing company. IGI will be responsible for developing two topical drug products, obtaining FDA marketing approvals, and manufacturing the commercial products.
It is critically important that colorectal cancer patients undergo colonoscopy after surgery to ensure that they do not have a second colon cancer, and to find and remove any additional polyps.
Congenital heart disease is the most common form of birth defect, affecting one out of every 125 babies, according to the National Institutes of Health. Researchers from the University of Missouri recently found success using a drug to treat laboratory mice with one form of congenital heart disease, hypertrophic cardiomyopathy - a weakening of the heart caused by abnormally thick muscle.
A new study in the American Journal of Preventive Medicine analyzing weekly patterns in health-related Google searches reveals a recurring pattern that could be leveraged to improve public health strategies.
› Verified 2 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
The National Academy of Sciences and the National Academy of Medicine are launching a major initiative to guide decision making about controversial new research involving human gene editing. Human gene-editing technologies, such as CRISPR-Cas9, may lead to promising new treatments for disease.
Impax Laboratories, Inc. today announced that it has entered into a product development and supply agreement with IGI Laboratories, Inc., a formulation and manufacturing company. IGI will be responsible for developing two topical drug products, obtaining FDA marketing approvals, and manufacturing the commercial products.
It is critically important that colorectal cancer patients undergo colonoscopy after surgery to ensure that they do not have a second colon cancer, and to find and remove any additional polyps.
Congenital heart disease is the most common form of birth defect, affecting one out of every 125 babies, according to the National Institutes of Health. Researchers from the University of Missouri recently found success using a drug to treat laboratory mice with one form of congenital heart disease, hypertrophic cardiomyopathy - a weakening of the heart caused by abnormally thick muscle.
A new study in the American Journal of Preventive Medicine analyzing weekly patterns in health-related Google searches reveals a recurring pattern that could be leveraged to improve public health strategies.
› Verified 2 days ago
Texas Health Presbyterian Hospital Allen Acute Care Hospital Location: 1105 Central Expressway North, Allen, Texas 75013 Phone: (972) 747-6197 | |
Our Childrens House Childrens Hospital Location: 8 Prestige Circle 101, Allen, Texas 75002 Phone: (214) 828-4747 |